Create Account | Sign In: Author or Forum

 
 
News  |  Journals  |  Conferences  |  Blogs  |  Articles  |  Forums  |  Twitter    
 

 Headlines:

 

Category: Family Medicine | Geriatrics | Internal Medicine | Nursing | Pharmacy | Rheumatology | Anesthesiology & Pain | Journal

Back to Journal Articles

DMARDs, Glucocorticoids, Biologics Similar for RA

Last Updated: October 01, 2010.

 

Equally effective at slowing joint destruction in rheumatoid arthritis

Share |

Comments: (0)

Tell-a-Friend

 

  Related
 
Treatment of rheumatoid arthritis with disease-modifying antirheumatic drugs, glucocorticoids, biologics, or a combination of these agents significantly reduces radiographic evidence of joint destruction, with no advantage seen for patients whose treatment includes biologics, according to research published in the October issue of Arthritis & Rheumatism.

FRIDAY, Oct. 1 (HealthDay News) -- Treatment of rheumatoid arthritis (RA) with disease-modifying antirheumatic drugs (DMARDs), glucocorticoids, biologics, or a combination of these agents significantly reduces radiographic evidence of joint destruction, with no advantage seen for patients whose treatment includes biologics, according to research published in the October issue of Arthritis & Rheumatism.

Niels Graudal, M.D., of the Copenhagen University Hospital, and Gesche Jürgens, M.D., of the Bispebjerg University Hospital -- both in Copenhagen, Denmark, reviewed 70 randomized, controlled trials that compared joint destruction in RA patients treated with DMARDs, glucocorticoids, and/or biologics. The percentage of annual radiographic progression rates (PARPRs) were compared for the various individual and combination treatments.

Compared to placebo, the researchers found that the PARPR was 0.90 percent smaller in the group treated with a single DMARD and 0.54 percent smaller in the group treated with glucocorticoids. Compared to the group receiving a single DMARD, the PARPR was 0.80 percent smaller in the DMARD combination group and 0.63 percent smaller in the biologic plus methotrexate (MTX) group. The effect of a combination of two DMARDs and step-down glucocorticoids did not differ significantly from that of a biologic combined with MTX.

"A direct comparison between a combination of biologic + MTX and a double DMARD combination + initial glucocorticoid revealed no difference. Consequently, biologics should still be reserved for DMARD-resistant patients. In the future, trials of the effect of biologics on RA should be compared with combination treatments involving DMARDs and glucocorticoids," the authors write.

Abstract
Full Text (subscription or payment may be required)

Copyright © 2010 HealthDay. All rights reserved.


Previous: Dog Ownership Reduces Risk of Eczema in Dog-Sensitive Children Next: Adding Rituximab to Chemo Improves Survival in Leukemia

Reader comments on this article are listed below. Review our comments policy.


Submit your opinion:

Name:

Email:

Location:

URL:

Remember my personal information

Notify me of follow-up comments?

advertisement.gif (61x7 -- 0 bytes)
 

Are you a Doctor, Pharmacist, PA or a Nurse?

Join the Doctors Lounge online medical community

  • Editorial activities: Publish, peer review, edit online articles.

  • Ask a Doctor Teams: Respond to patient questions and discuss challenging presentations with other members.

Doctors Lounge Membership Application

 
     

 advertisement.gif (61x7 -- 0 bytes)

 

 

Useful Sites
MediLexicon
  Tools & Services: Follow DoctorsLounge on Twitter Follow us on Twitter | RSS News | Newsletter | Contact us
Copyright © 2001-2013
Doctors Lounge.
All rights reserved.

Medical Reference:
Diseases | Symptoms
Drugs | Labs | Procedures
Software | Tutorials

Advertising
Links | Humor
Forum Archive
CME | Conferences

Privacy Statement
Terms & Conditions
Editorial Board
About us | Email

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.